Company Filing History:
Years Active: 2024
Title: Lok Hang Mak - Innovator in T Cell Receptor Technology.
Introduction
Lok Hang Mak is a prominent inventor based in Abingdon, GB. He has made significant contributions to the field of immunology, particularly in the development of T cell receptor (TCR) fusion proteins. His innovative work has the potential to advance therapeutic strategies in cancer treatment and other diseases.
Latest Patents
Lok Hang Mak holds a patent for T cell receptors and fusion proteins thereof. The patent details T cell receptor fusion proteins that bind to a specific HLA-A*02 complex, covalently linked to a T cell engaging domain and an antibody Fc domain. This invention also encompasses related polynucleotides, vectors, kits, host cells, pharmaceutical compositions, methods, and uses.
Career Highlights
Mak is associated with Immunocore Limited, a company known for its pioneering work in T cell therapy. His role at the company has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Paul Conroy and Stephen Hearty, who have also made significant contributions to the field of immunology.
Conclusion
Lok Hang Mak's innovative work in T cell receptor technology exemplifies the advancements being made in immunotherapy. His contributions are paving the way for new treatment options in the medical field.